RESOLVED2

REcommander System in Oncology with ML to Enhance Drug Development.

As soon as oncology Phase 1 clinical trial completion, RESOLVED2 can predict accurately the time to FDA approval. We provide the proof of concept that drug development outcome can be predicted by machine learning strategies.

See JCO-CCI publication

Check our online predictive tools for prospective evaluation of RESOLVED2